default author photo

Michael D. Rosenblum

University of California, San Francisco (UCSF) - Department of Dermatology

Third Avenue and Parnassus

San Francisco, CA 94143

United States

SCHOLARLY PAPERS

2

DOWNLOADS

98

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

In Situ Transfection of Interleukin 12 Plasmid Enhances Anti-PD-1 Immune Response in Patients with Immunologically Quiescent Melanoma

Number of pages: 37 Posted: 05 Mar 2019
University of California, San Francisco (UCSF) - Department of Medicine, OncoSec Inc, University of California, San Francisco (UCSF) - Department of Medicine, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, OncoSec Inc, OncoSec Inc, OncoSec Inc, OncoSec Inc, University of California, San Francisco (UCSF) - Department of Medicine, OncoSec Inc, University of California, San Francisco (UCSF) - Department of Medicine, Massachusetts General Hospital - Center for Systems Biology, Massachusetts General Hospital - Center for Systems Biology, Massachusetts General Hospital - Center for Systems Biology, OncoSec Inc, University of California, San Francisco (UCSF) - Department of Medicine, University of California, San Francisco (UCSF) - Department of Medicine, Fred Hutchinson Cancer Research Center, Merck & Co., Inc., Huntsman Cancer Institute, Providence Cancer Center - Earle A. Chiles Research Institute, University of California, San Francisco (UCSF) - Department of Dermatology and University of California, San Francisco (UCSF) - Department of Medicine
Downloads 57 (989,921)

Abstract:

Loading...

2.

Integrin αvβ8 on T Cells is Responsible for Suppression of Anti-Tumor Immunity in Syngeneic Models and is a Promising Target for Tumor Immunotherapy

Number of pages: 53 Posted: 19 May 2020
University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - Lung Biology Center, University of California, San Francisco (UCSF) - Lung Biology Center, University of California, San Francisco (UCSF) - Lung Biology Center, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - Lung Biology Center, University of California, San Francisco (UCSF) - Lung Biology Center, University of California, San Francisco (UCSF) - Department of Dermatology, University of California, San Francisco (UCSF) - Department of Dermatology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - Lung Biology Center, University of California, San Francisco (UCSF) - Lung Biology Center, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, Pfizer, Inc. - Comparative Medicine, Pfizer, Inc. - Oncology Research Unit, Pfizer, Inc. - Oncology Research Unit, Pfizer, Inc. - Oncology Research Unit, Pfizer Centers for Therapeutic Innovation, University of California, San Francisco (UCSF) - Lung Biology Center, Pfizer Centers for Therapeutic Innovation, University of California, San Francisco (UCSF) - Lung Biology Center, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center and University of California, San Francisco (UCSF) - Lung Biology Center
Downloads 41 (1,170,409)
Citation 1

Abstract:

Loading...